Larazotide acetate clinical trials
Also written INN-202 and AT-1001.
Its developmentBy 9 Meters Biopharma, BioMarin Pharmaceutical and Interlude Biopharma, step by step12 company-led studies, furthest phase 3: when each phase was reached, its deals, target and what is ahead.A product of Larazotide; its studies count on that page too.
How each study uses larazotide acetate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the larazotide acetate studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
12 studies that test it; most in 2011 (4); 1 more planned to start later
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 4 |
| 2021 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 11 · Other 2
9 Meters Biopharma, Inc. (7) · Amicus Therapeutics (3) · Massachusetts General Hospital (2) · Interlude Biopharma Co. (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- A salt or form of Larazotide
Studies
Open first, then newest update. How each study uses larazotide acetate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 13
- Clinical Trial to Evaluate the Protective Effect of Larazotide Acetate in Individuals With Well-Controlled Celiac DiseaseNot yet recruitingPhase 3Interlude Biopharma Co.NCT07944625Written as Larazotide AcetateHow we know
- AT1001 for the Treatment of Long COVIDCompletedPhase 2Massachusetts General HospitalNCT05747534Written as Larazotide AcetateHow we know
- AT1001 for the Treatment of COVID-19 Related MIS-CTerminatedPhase 2Massachusetts General HospitalNCT05022303Written as Larazotide AcetateHow we know
- Study of the Efficacy of Larazotide Acetate to Treat Celiac DiseaseCompletedPhase 29 Meters Biopharma, Inc.NCT00889473Written as Larazotide acetateHow we know
- Study to Assess the Efficacy of Larazotide Acetate for the Treatment of Celiac DiseaseCompletedPhase 29 Meters Biopharma, Inc.NCT00492960Written as larazotide acetateHow we know
- A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac DiseaseCompletedPhase 29 Meters Biopharma, Inc.NCT01396213Written as Larazotide AcetateHow we know
- Randomized, Double-Blind, Placebo-Controlled Study of Larazotide Acetate in Subjects With Active Celiac DiseaseCompletedPhase 29 Meters Biopharma, Inc.NCT00620451Written as larazotide acetateHow we know
- Safety of Larazotide Acetate in Healthy VolunteersCompletedPhase 19 Meters Biopharma, Inc.NCT00386490Written as larazotide acetateHow we know
- Safety and Tolerability Study of Larazotide Acetate in Celiac Disease SubjectsCompletedPhase 29 Meters Biopharma, Inc.NCT00362856Written as larazotide acetateHow we know
- Safety Study of Larazotide Acetate to Treat Celiac Disease.CompletedPhase 19 Meters Biopharma, Inc.NCT00386165Written as larazotide acetateHow we know
- Safety and Pharmacokinetics of AT1001 (Migalastat HCl) in Healthy Subjects and Subjects With Impaired Renal FunctionCompletedPhase 1Amicus TherapeuticsNCT01730469Written as AT1001 150 mgHow we know
- A Study to Assess the Absorption, Metabolism and Excretion of Migalastat Hydrochloride (AT1001-014)CompletedPhase 1Amicus TherapeuticsNCT01730482Written as [14C] AT1001How we know
- A Phase I, Randomized, Single-Blind, Four-Period Cross-Over, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Single Oral Doses of GR181413A/AT1001 in Healthy Japanese SubjectsCompletedPhase 1Amicus TherapeuticsNCT01853852Written as GR181413A/AT1001 solutionHow we know
What changed recently
From the registry's own updates since Oct 20, 2026.
Newly registered1
Codes
What other systems call larazotide acetate · ClinicalTrials.gg INT005200
- MeSH (NLM) C525167larazotide acetateOne source NLM
- UNII (FDA) FO8S2IW40NLARAZOTIDE ACETATEConfirmed FDA, NLM
- NCI Thesaurus C81670Larazotide AcetateOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C525167 | larazotide acetate | One source NLM |
| UNII (FDA) | FO8S2IW40N | LARAZOTIDE ACETATE | Confirmed FDA, NLM |
| NCI Thesaurus | C81670 | Larazotide Acetate | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.